Would you have Granuloma annulare when you have Multiple sclerosis?
Summary: Granuloma annulare is found among people with Multiple sclerosis, especially people who are female, 40-49 old, also have Depression, and take medication Tysabri.
We study 13 people who have Granuloma annulare and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.
You are not alone: join a mobile support group for people who have Multiple sclerosis and Granuloma annulare >>>
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Betaseron, Baclofen. (latest reports from 224,269 Multiple Sclerosis patients)
Granuloma annulare (reddish bumps on the skin arranged in a circle or ring) has been reported by people with depression, high blood pressure, rheumatoid arthritis, osteoporosis, multiple sclerosis. (latest reports from 334 Granuloma annulare patients)
On Feb, 25, 2015: 13 people who have multiple sclerosis and Granuloma Annulare are studied.
Gender of people who have multiple sclerosis and experienced Granuloma annulare * :
|Granuloma annulare||100.00%||0.00% |
Age of people who have multiple sclerosis and experienced Granuloma annulare * :
|Granuloma annulare||0.00%||0.00%||0.00%||0.00%||14.29%||14.29%||50.00%||21.43% |
Severity of the symptom * :
|least||moderate||severe||most severe |
|Granuloma annulare||0.00%||100.00%||0.00%||0.00% |
Top co-existing conditions for these people * :
- Depression (4 people, 30.77%)
- Chronic fatigue syndrome (2 people, 15.38%)
- Abnormal faeces (2 people, 15.38%)
- Multiple allergies (2 people, 15.38%)
- Gastrooesophageal reflux disease (2 people, 15.38%)
- Affective disorder (2 people, 15.38%)
Most common drugs used by these people * :
- Tysabri (5 people, 38.46%)
- Effexor xr (4 people, 30.77%)
- Betaseron (3 people, 23.08%)
- Avonex (3 people, 23.08%)
- Copaxone (2 people, 15.38%)
- Lyrica (2 people, 15.38%)
- Januvia (2 people, 15.38%)
- Lamictal (2 people, 15.38%)
- Baclofen (2 people, 15.38%)
- Topamax (2 people, 15.38%)
* Approximation only. Some reports may have incomplete information.
Comments for this study:
carol (2 years ago):
I had GA on the top of my right foot when I was a teenager. Dr had no idea what it was and it went away after 6 months or so. At 35 I was dx with Multiple Sclerosis. And am now 43 and on Copaxone. Never connected the two things! Wow! Hmmm
Reply the comment
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of multiple sclerosis and granuloma annulare on
Do you have Multiple Sclerosis and Granuloma Annulare?
You are not alone! Join a mobile support group on :
- support group for people who have Granuloma Annulare and Multiple sclerosis
- support group for people who have Multiple sclerosis
- support group for people who have Granuloma Annulare
Could your drug cause:
Other conditions that could cause:
Recent Multiple Sclerosis related drug comparison:
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.